tetano
Editor, Senior Moderator
Cureus
. 2022 Nov 28;14(11):e31986.
doi: 10.7759/cureus.31986. eCollection 2022 Nov.
Bilateral Cavernous Sinus Thrombosis in Presumed COVID-19 Infection
Stephen A LoBue[SUP] 1 [/SUP], Royce Park[SUP] 1 [/SUP], Richard Giovane[SUP] 2 [/SUP], John DeLury[SUP] 3 [/SUP], Nickisa Hodgson[SUP] 1 [/SUP]
Affiliations
Abstract
Cavernous sinus thrombosis (CST) is a rare life-threatening condition where a blood clot develops within the cavernous sinus secondary to various etiologies, ranging from infection to aseptic causes (e.g., trauma or surgery). The dural sinuses and the cerebral veins have no valves, which allow retrograde blood flow according to pressure gradients. As a result, cavernous sinuses are vulnerable to septic thrombosis from infection at various sites including sphenoid and ethmoid sinuses. Less commonly, infections of the face, ears, nose, tonsils, soft palate, and teeth may lead to CST if treatment is delayed. Clinical findings of CST extending to the opposite cavernous sinus typically requires 24-48 hours after the initial presentation of orbital signs. However, we present a patient with facial and orbital cellulitis that was immediately treated with high-dose IV antibiotics within one hour of presentation and IV heparin six hours after admission and CST diagnosis. However, the patient developed a rapid progression of bilateral CST within six hours, unresponsive to treatment. Although facial cellulitis may lead to septic CST if untreated, the rapid progression of bilateral CST in the setting of acute hypoxic respiratory failure, renal failure, and coagulation abnormalities suggests a possible underlying infection and complications similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Keywords: bilateral cavernous sinus thrombosis; covid-19; orbital cellulitis; septic cavernous sinus thrombosis; severe acute respiratory syndrome coronavirus 2 (sars-cov-2).
. 2022 Nov 28;14(11):e31986.
doi: 10.7759/cureus.31986. eCollection 2022 Nov.
Bilateral Cavernous Sinus Thrombosis in Presumed COVID-19 Infection
Stephen A LoBue[SUP] 1 [/SUP], Royce Park[SUP] 1 [/SUP], Richard Giovane[SUP] 2 [/SUP], John DeLury[SUP] 3 [/SUP], Nickisa Hodgson[SUP] 1 [/SUP]
Affiliations
- PMID: 36589184
- PMCID: PMC9797752
- DOI: 10.7759/cureus.31986
Abstract
Cavernous sinus thrombosis (CST) is a rare life-threatening condition where a blood clot develops within the cavernous sinus secondary to various etiologies, ranging from infection to aseptic causes (e.g., trauma or surgery). The dural sinuses and the cerebral veins have no valves, which allow retrograde blood flow according to pressure gradients. As a result, cavernous sinuses are vulnerable to septic thrombosis from infection at various sites including sphenoid and ethmoid sinuses. Less commonly, infections of the face, ears, nose, tonsils, soft palate, and teeth may lead to CST if treatment is delayed. Clinical findings of CST extending to the opposite cavernous sinus typically requires 24-48 hours after the initial presentation of orbital signs. However, we present a patient with facial and orbital cellulitis that was immediately treated with high-dose IV antibiotics within one hour of presentation and IV heparin six hours after admission and CST diagnosis. However, the patient developed a rapid progression of bilateral CST within six hours, unresponsive to treatment. Although facial cellulitis may lead to septic CST if untreated, the rapid progression of bilateral CST in the setting of acute hypoxic respiratory failure, renal failure, and coagulation abnormalities suggests a possible underlying infection and complications similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Keywords: bilateral cavernous sinus thrombosis; covid-19; orbital cellulitis; septic cavernous sinus thrombosis; severe acute respiratory syndrome coronavirus 2 (sars-cov-2).